Treatment of non-alcoholic fatty liver disease: an interpretation of the European clinical guidelines for obesity, type 2 diabetes, and digestive disease
10.3760/cma.j.issn.1007-3418.2017.02.008
- VernacularTitle: 非酒精性脂肪性肝病的治疗：欧洲肥胖-2型糖尿病-消化临床实践指南解读
- Author:
Fangping HE
1
Author Information
1. Department of Hepatology, the First Affiliated Hospital of Xinjiang Medical University, Urumqi 830011, China
- Publication Type:Journal Article
- Keywords:
Fatty liver;
Treatment;
Guideline;
Interpretation
- From:
Chinese Journal of Hepatology
2017;25(2):119-121
- CountryChina
- Language:Chinese
-
Abstract:
Although many Chinese and international guidelines offer recommendations for the treatment of nonalcoholic fatty liver disease (NAFLD), there are also confusions in clinical practice, including the differences in drug indications, drug selection, the basic principles of lifestyle intervention, and key points in individual regimens between Chinese and international guidelines. In addition, there are also differences in many aspects including medical model and medical insurance system between the East and the West. These differences are great challenges for clinical practice, and the hepatologists in China have to face the challenges of localization when following the guidelines for the treatment of NAFLD.
